Insider Buy/Sell Details for the Healthcare Sector — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1335)
Hims & Hers Health, Inc. (HIMS)
Okupe Oluyemi — Chief Financial Officer
Shares
19,645
Price
$29.96
Total Value
$588.62K
Shares Held After
262,954
% of Holdings
7.0%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
37,382
Price
$1.01
Total Value
$37.62K
Shares Held After
1,769,963
% of Holdings
2.1%
Hims & Hers Health, Inc. (HIMS)
Boughton Soleil — Chief Legal Officer
Shares
9,463
Price
$30.00
Total Value
$283.89K
Shares Held After
299,368
% of Holdings
3.1%
REVVITY, INC. (RVTY)
Gonzales Anita — Vice President and CAO
Shares
80
Price
$92.80
Total Value
$7.42K
Shares Held After
7,319
% of Holdings
1.1%
ENSIGN GROUP, INC (ENSG)
Agwunobi John O — Director
Shares
392
Price
$199.97
Total Value
$78.39K
Shares Held After
9,295
% of Holdings
4.0%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
83,712
Price
$1.01
Total Value
$84.25K
Shares Held After
3,776,135
% of Holdings
2.2%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
1,420
Price
$93.90
Total Value
$133.34K
Shares Held After
2,205,000
% of Holdings
0.1%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
3,580
Price
$93.14
Total Value
$333.44K
Shares Held After
2,206,420
% of Holdings
0.2%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
100,000
Price
$1.58
Total Value
$158.00K
Shares Held After
9,878,988
% of Holdings
1.0%
Planet 13 Holdings Inc. (PLNH)
Wren Chris — VP of Operations
Shares
30,000
Price
$0.15
Total Value
$4.52K
Shares Held After
5,077,784
% of Holdings
0.6%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
171,963
Price
$15.77
Total Value
$2.71M
Shares Held After
2,567,245
% of Holdings
6.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.55
Total Value
$277.32K
Shares Held After
399,484
% of Holdings
4.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
9
Price
$168.35
Total Value
$1.52K
Shares Held After
12,666
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
16
Price
$167.16
Total Value
$2.67K
Shares Held After
12,675
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
3
Price
$166.91
Total Value
$500.72
Shares Held After
12,691
% of Holdings
0.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
40
Price
$165.29
Total Value
$6.61K
Shares Held After
12,694
% of Holdings
0.3%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
124
Price
$164.40
Total Value
$20.39K
Shares Held After
12,734
% of Holdings
1.0%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
524
Price
$163.52
Total Value
$85.68K
Shares Held After
12,858
% of Holdings
3.9%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
284
Price
$162.76
Total Value
$46.22K
Shares Held After
13,382
% of Holdings
2.1%
Phreesia, Inc. (PHR)
Hoffman Allison C — General Counsel & Secretary
Shares
6,176
Price
$9.06
Total Value
$55.95K
Shares Held After
157,309
% of Holdings
3.8%
Protagonist Therapeutics, Inc (PTGX)
Ali Asif — Chief Financial Officer
Shares
1,750
Price
$105.47
Total Value
$184.57K
Shares Held After
59,003
% of Holdings
2.9%
SOPHiA GENETICS SA (SOPH)
Van Well Daan — Chief Legal Officer
Shares
684
Price
$5.20
Total Value
$3.55K
Shares Held After
345,736
% of Holdings
0.2%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
4,486
Price
$5.21
Total Value
$23.35K
Shares Held After
3,642,481
% of Holdings
0.1%
SOPHiA GENETICS SA (SOPH)
Puylaert Kevin — Chief Sales Officer
Shares
33
Price
$5.08
Total Value
$167.69
Shares Held After
148,197
% of Holdings
0.0%
SOPHiA GENETICS SA (SOPH)
Valente Manuela — Chief People Officer
Shares
380
Price
$5.20
Total Value
$1.98K
Shares Held After
215,071
% of Holdings
0.2%
SOPHiA GENETICS SA (SOPH)
Xu Zhenyu — Chief Scientific Officer
Shares
608
Price
$5.21
Total Value
$3.16K
Shares Held After
630,888
% of Holdings
0.1%
SOPHiA GENETICS SA (SOPH)
Muken Ross — President
Shares
760
Price
$5.20
Total Value
$3.95K
Shares Held After
681,672
% of Holdings
0.1%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
608
Price
$5.20
Total Value
$3.16K
Shares Held After
266,388
% of Holdings
0.2%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
125,274
Price
$20.07
Total Value
$2.51M
Shares Held After
4,207,525
% of Holdings
2.9%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
94,462
Price
$0.75
Total Value
$70.85K
Shares Held After
83,359
% of Holdings
53.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$586.47
Total Value
$23.46K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
163
Price
$585.50
Total Value
$95.44K
Shares Held After
40,553
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
509
Price
$584.39
Total Value
$297.45K
Shares Held After
40,716
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
848
Price
$583.41
Total Value
$494.74K
Shares Held After
41,225
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,070
Price
$582.46
Total Value
$623.23K
Shares Held After
42,073
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
238
Price
$585.36
Total Value
$139.32K
Shares Held After
18,876
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
410
Price
$581.71
Total Value
$238.50K
Shares Held After
43,143
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
482
Price
$584.49
Total Value
$281.73K
Shares Held After
19,114
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,009
Price
$583.55
Total Value
$588.80K
Shares Held After
19,596
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
277
Price
$579.92
Total Value
$160.64K
Shares Held After
43,553
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
461
Price
$579.09
Total Value
$266.96K
Shares Held After
43,830
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
983
Price
$582.47
Total Value
$572.57K
Shares Held After
20,605
% of Holdings
4.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
488
Price
$581.66
Total Value
$283.85K
Shares Held After
21,588
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
165
Price
$577.94
Total Value
$95.36K
Shares Held After
44,291
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
340
Price
$579.86
Total Value
$197.15K
Shares Held After
22,076
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,148
Price
$576.87
Total Value
$662.25K
Shares Held After
44,456
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
500
Price
$578.90
Total Value
$289.45K
Shares Held After
22,416
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,179
Price
$575.96
Total Value
$679.05K
Shares Held After
45,604
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
687
Price
$577.27
Total Value
$396.58K
Shares Held After
22,916
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
570
Price
$575.07
Total Value
$327.79K
Shares Held After
46,783
% of Holdings
1.2%
Showing 251–300 of 1335 transactions (page 6 of 27)